
Gypenoside BP2213
绞股蓝皂苷BP2213
PHY-NP-00395 · Natural product research catalog
| Catalog number | PHY-NP-00395 |
|---|---|
| CAS number | 862286-45-1 |
| Molecular formula | C49H78O18 |
| Molecular weight | 955.145 g/mol |
| Chemical class | Triterpenoids |
| Main reported source | Coleostephus myconis |
| Purity / assay | Min. 98% Other purity specifications available on inquiry. |
Chemical structure

Select a pack size
| Pack | Price (USD) | Availability | Lead time |
|---|---|---|---|
| 5 mg | Request quote | To be confirmed | Confirm in quotation |
| 10 mg | Request quote | To be confirmed | Confirm in quotation |
| 20 mg | Request quote | To be confirmed | Confirm in quotation |
| 50 mg | Request quote | To be confirmed | Confirm in quotation |
| 100 mg | Request quote | To be confirmed | Confirm in quotation |
Final specifications and availability are confirmed in your quotation. No purchase or reservation is made here.
Larger pack sizes available — Request a quote
Request larger pack sizes / bulk quantity ↗
Telephone contact details will be published after launch.
Product information
Gypenoside BP2213 is listed in the Triterpenoids section of the Phytide Bio research catalog. Standard pack sizes are 5, 10, 20, 50 and 100 mg.
For research use only. Not for human or veterinary use, diagnosis or treatment.
Names & identifiers
| IUPAC name | [(2R,3R,4S,5R,6R)-3-hydroxy-6-[[(3S,5R,8R,9R,10R,13R,14R,17S)-17-[(3S,5S)-3-hydroxy-5-(2-methylprop-1-enyl)-2-oxooxolan-3-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]methyl acetate |
|---|---|
| SMILES | C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3CC[C@@]4([C@H]5CC[C@@H]6[C@H](CC[C@]6([C@@]5(CC[C@H]4C3(C)C)C)C)[C@]7(C[C@H](OC7=O)C=C(C)C)O)C)COC(=O)C)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O)O)O |
| InChIKey | AXBJYHWXSQPRFA-VQMBBYARSA-N |
| Subclass / scaffold | Dammarane and Protostane triterpenoids;皂苷/苷 |
| PubChem CID | 101721175 |
Computed properties
| Exact mass (Da) | 954.5188 | Predicted LogP | 1.7553 |
|---|---|---|---|
| Predicted TPSA (Ų) | 269.82 | H-bond donors | 8 |
| H-bond acceptors | 18 | Rotatable bonds | 10 |
Calculated values from the supplied dataset; not measured batch specifications.
View additional properties & classification
| Ring count | 8 |
|---|---|
| Aromatic rings | 0 |
| Fraction Csp³ | 0.918 |
| Synthetic accessibility score | 6.48 |
| QED score | 0.088 |
| Lipinski rule violations | 3 |
| NPClassifier pathway | Terpenoids |
| NPClassifier superclass | Triterpenoids |
| NPClassifier class | Dammarane and Protostane triterpenoids |
| Parent SMILES | CC(=O)OC[C@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@@H]5[C@@H]([C@@]6(O)C[C@@H](C=C(C)C)OC6=O)CC[C@@]5(C)[C@]4(C)CC[C@H]3C2(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O |
| Parent formula | C49H78O18 |
| Parent molecular weight | 955.145 |
| Specified stereocenters | 24 |
| Unspecified stereocenters | 0 |
Reported natural occurrence
| Main reported source | Coleostephus myconis |
|---|
Reported natural occurrence does not establish the manufacturing origin of the supplied material.
View occurrence records & references
| LOTUS species records | 0 |
|---|---|
| LOTUS reference records | 0 |
| COCONUT occurrence records | Coleostephus myconis; Dahlia pinnata; Gynostemma pentaphyllum; Pertusaria wulfenii; Synotis alata |
| COCONUT organism records | 5 |
| COCONUT identifier | CNP0241239.1 |
Records are inherited from the supplied dataset and are not independently verified. Taxonomic names may include synonyms.
Documents & specifications
| Certificate of analysis (COA) | Batch-specific COA available on request; no PDF published yet |
|---|---|
| Safety data sheet (SDS) | Not yet published |
| Storage / solubility | Product-specific conditions to be confirmed |
| Shipping | Confirmed with the quotation |
Request applicable documentation and handling information before ordering or use.
![Chemical structure of (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2R)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol](/structures/PHY-NP-00334.webp)


![Chemical structure of (3I(2),16I(2),23R)-16,23:16,30-Diepoxy-20-hydroxydammar-24-en-3-yl O-6-deoxy-I+/--L-mannopyranosyl-(1a2)-O-[O-I(2)-D-xylopyranosyl-(1a2)-6-O-acetyl-I(2)-D-glucopyranosyl-(1a3)]-I+/--L-arabinopyranoside](/structures/PHY-NP-00336.webp)
![Chemical structure of (3S,5R,6S,8R,9R,10R,13R,14R,17S)-3,6-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-1,2,3,5,6,7,9,11,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-12-one](/structures/PHY-NP-00337.webp)